Browse the complete record of transactions filed by Strobeck Matthew, Director. Director active across 4 companies, notably QUIDEL CORP. In total, 11 reports have been recorded. Total volume traded: €2m. The latest transaction was filed on 18 May 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is free.
Matthew Strobeck serves as a Board Member at Quidel Corp, Accelerate Diagnostics, Inc, and Biodesix Inc. As a board member, he plays a key role in the governance and strategy of the companies. His expertise is essential for their development.